3 articles
Indian equities opened lower as escalating Middle East conflict drove Brent crude to $96.6 per barrel, fueling inflation worries. Corporate highlights included Gland Pharma receiving zero observations
India's Gland Pharma beat quarterly profit estimates with a $33.3 million net profit, driven by 32% U.S. and 20% European sales growth. Recovery at its Cenexi production units in France and Belgium su
Indian stocks and the rupee declined as Middle East tensions pushed Brent crude to $112 per barrel. While Reliance and Tata Steel fell, Gland Pharma surged on strong quarterly profits.
ChemBrief